ROBIN DAILEY: Open Payments
NPI 1265893051 · MARION, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,741 in 137 payments from 20 companies in 2025. Trend: 2023 $2,940 · 2024 $2,871 · 2025 $2,741
Food & beverage: $2,741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $689 |
| AstraZeneca Pharmaceuticals LP | 9 | $501 |
| Axsome Therapeutics, Inc. | 9 | $284 |
| Novo Nordisk Inc | 16 | $233 |
| Lilly USA, LLC | 12 | $202 |
| GlaxoSmithKline, LLC. | 10 | $164 |
| Sumitomo Pharma America, Inc. | 9 | $145 |
| Abbott Laboratories | 6 | $108 |
| PFIZER INC. | 5 | $89 |
| Dexcom, Inc. | 3 | $76 |
Products named: BREZTRI, VRAYLAR, Auvelity, UBRELVY, MOUNJARO, TRELEGY ELLIPTA, Ozempic, GEMTESA.
Industry payments across IL — which companies pay providers there.
